Neurological Disorders Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Neurological Disorders

Neurological disorders are defined as disorders that affect the brain, spine and nerves throughout the human body. It is either associated with CNS or PNS or both. Structural, biochemical or electrical abnormalities can cause a wide range of neurological problems which eventually might lead to different types of mild to severe neurological disorders.

Neurological disorders have different causes and symptoms. Most of them start or emerge during the early stage of life or maybe diagnosed at birth. The symptoms of Neurological disorders vary in each disorder. Congenital causes, gene abnormalities, metabolic disorders, prenatal causes, nutritional deficiencies, complications during childbirth, acquired causes, immune disorders, traumatic brain injury, and toxins are some of the causes of Neurological disorders.

Some neurological disorders are:

Parkinson's disease
Amyotrophic lateral sclerosis or ALS
Brain tumors
Epilepsy
Stroke
Peripheral Neuropathy
Key treatment methods of Neurological disorders:

Neuroimaging techniques to diagnose
Brain mapping
Cognitive therapy treatment
Pain management
Physiotherapy
Deep brain stimulation
There are various other methods to treat these lifelong neurological disorders.

Sub-tracks:

ALS
Epilepsy
Parkinson's Disease
Brain Aneurysm
Spinal Cord Tumor
Memory Disorders
Multiple Sclerosis
Arteriovenous Malformation
Headache
Dural Arteriovenous Fistulae
Stroke
Brain Tumors
Peripheral Neuropathy
Post-Herpetic Neuralgia

Market Analysis: The Neurological Disorders market is set for significant growth from 2025-2030, driven by rising global prevalence, an aging population, and continuous advancements in diagnostics and therapeutics. The Neurological Disorder Diagnostics Treatment Market alone is projected to grow at a CAGR of about 5.68%, reaching an estimated US$18.903 billion by 2030. This expansion is further bolstered by growth in related sectors like the Neuro Navigation Systems Market (6.04% CAGR), Neurology Devices Market (7.2% to 8.9% CAGR), and the broader Neurotechnology Market (13.53% CAGR). Additionally, the Neurological Biomarkers Market is estimated at around a 10% CAGR, while the Central Nervous System (CNS) Therapeutics Market is projected for a significant 10.46% CAGR (2025-2035). This strong momentum is broadly driven by ongoing breakthroughs in neuroscience, the integration of AI-enabled technologies, increasing demand for enhanced treatment options, and rising public and private investment in neurological research.

Tracks